MUC1 and ovarian cancer: Moving on to the in vivo experiments, the data show that [89Zr]Zr-DFO-AR20.5 is capable of clearly visualizing MUC1-expressing tumor tissue in mice bearing both subcutaneous and orthotopic ovarian cancer xenografts.